Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4067329
Max Phase: Preclinical
Molecular Formula: C41H59N13O6
Molecular Weight: 830.01
Molecule Type: Small molecule
Associated Items:
ID: ALA4067329
Max Phase: Preclinical
Molecular Formula: C41H59N13O6
Molecular Weight: 830.01
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)NN(CCCCCN)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O
Standard InChI: InChI=1S/C41H59N13O6/c1-26(49-39(58)35(21-28-23-47-32-15-7-6-14-30(28)32)51-38(57)31(44)22-29-24-46-25-48-29)37(56)53-54(19-11-3-9-17-42)41(60)52-34(20-27-12-4-2-5-13-27)40(59)50-33(36(45)55)16-8-10-18-43/h2,4-7,12-15,23-26,31,33-35,47H,3,8-11,16-22,42-44H2,1H3,(H2,45,55)(H,46,48)(H,49,58)(H,50,59)(H,51,57)(H,52,60)(H,53,56)/t26-,31-,33-,34+,35+/m0/s1
Standard InChI Key: ZLUKSRCLMYMDIY-NXTWHFHVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 830.01 | Molecular Weight (Monoisotopic): 829.4711 | AlogP: -0.12 | #Rotatable Bonds: 24 |
Polar Surface Area: 314.36 | Molecular Species: BASE | HBA: 10 | HBD: 11 |
#RO5 Violations: 2 | HBA (Lipinski): 19 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.51 | CX Basic pKa: 10.49 | CX LogP: -2.11 | CX LogD: -7.20 |
Aromatic Rings: 4 | Heavy Atoms: 60 | QED Weighted: 0.03 | Np Likeness Score: -0.04 |
1. Chignen Possi K, Mulumba M, Omri S, Garcia-Ramos Y, Tahiri H, Chemtob S, Ong H, Lubell WD.. (2017) Influences of Histidine-1 and Azaphenylalanine-4 on the Affinity, Anti-inflammatory, and Antiangiogenic Activities of Azapeptide Cluster of Differentiation 36 Receptor Modulators., 60 (22): [PMID:29028172] [10.1021/acs.jmedchem.7b01209] |
Source(1):